Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy
Abstract Objective Anti‐CD20 therapy is a highly effective treatment for multiple sclerosis (MS). In this study, we investigated MS‐related changes in peripheral blood mononuclear cell (PBMC) subsets compared to healthy controls and longitudinal changes related to the treatment. Methods Multicolor s...
Saved in:
| Main Authors: | Mie Waede, Lasse F. Voss, Christina Kingo, Jesper B. Moeller, Maria L. Elkjaer, Zsolt Illes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Annals of Clinical and Translational Neurology |
| Online Access: | https://doi.org/10.1002/acn3.52182 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis
by: Alice G. Willison, et al.
Published: (2025-04-01) -
A role of CD20+ T cells in early multiple sclerosis
by: Marina Rode von Essen, et al.
Published: (2025-05-01) -
Role of CD20<sup>+</sup>T lymphocytes in the pathogenesis of multiple sclerosis
by: N. S. Glebezdina
Published: (2024-07-01) -
Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study
by: André Aires Fernandes, et al.
Published: (2025-01-01) -
The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01)